PGNY Progyny Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: PGNY

Price (delayed)

$32.6

Market cap

$3.15B

P/E Ratio

50.15

Dividend/share

N/A

EPS

$0.65

Enterprise value

$3.07B

Progyny is a leading fertility benefits management company in the US. The company is redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously ...

Highlights
The net income has soared by 104% YoY and by 19% from the previous quarter
The EPS has surged by 97% year-on-year and by 16% since the previous quarter
The company's debt has surged by 166% YoY but it fell by 2.6% QoQ
Sector: Healthcare
Industry: Health Information Services
Website: http://www.progyny.com

Key stats

What are the main financial stats of PGNY
Market
Shares outstanding
96.5M
Market cap
$3.15B
Enterprise value
$3.07B
Valuations
Price to earnings (P/E)
50.15
Price to book (P/B)
5.65
Price to sales (P/S)
2.85
EV/EBIT
45.5
EV/EBITDA
44.01
EV/Sales
2.82
Earnings
Revenue
$1.09B
EBIT
$67.39M
EBITDA
$69.67M
Free cash flow
$185.17M
Per share
EPS
$0.65
Free cash flow per share
$1.95
Book value per share
$5.77
Revenue per share
$11.46
TBVPS
$7.84
Balance sheet
Total assets
$756.62M
Total liabilities
$203.19M
Debt
$17.24M
Equity
$553.43M
Working capital
$454.46M
Liquidity
Debt to equity
0.03
Current ratio
3.44
Quick ratio
3.3
Net debt/EBITDA
-1.15
Margins
EBITDA margin
6.4%
Gross margin
21.9%
Net margin
5.7%
Operating margin
5.7%
Efficiency
Return on assets
8.8%
Return on equity
12.6%
Return on invested capital
18.2%
Return on capital employed
11.8%
Return on sales
6.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PGNY stock price

How has the Progyny stock price performed over time
Intraday
0.62%
1 week
-0.46%
1 month
-12.46%
1 year
-5.56%
YTD
-12.32%
QTD
-14.55%

Financial performance

How have Progyny's revenue and profit performed over time
Revenue
$1.09B
Gross profit
$238.8M
Operating income
$62.18M
Net income
$62.04M
Gross margin
21.9%
Net margin
5.7%
Progyny's operating income has surged by 166% YoY and by 20% QoQ
The net income has soared by 104% YoY and by 19% from the previous quarter
PGNY's operating margin has surged by 90% year-on-year and by 14% since the previous quarter
The company's net margin rose by 46% YoY and by 14% QoQ

Growth

What is Progyny's growth rate over time

Valuation

What is Progyny stock price valuation
PGNY P/E details
P/E
50.15
P/B
5.65
P/S
2.85
EV/EBIT
45.5
EV/EBITDA
44.01
EV/Sales
2.82
The EPS has surged by 97% year-on-year and by 16% since the previous quarter
The stock's price to earnings (P/E) is 23% less than its last 4 quarters average of 65.1
PGNY's price to book (P/B) is 62% lower than its 5-year quarterly average of 14.9 and 18% lower than its last 4 quarters average of 6.9
PGNY's equity is up by 47% year-on-year and by 7% since the previous quarter
PGNY's price to sales (P/S) is 57% lower than its 5-year quarterly average of 6.6 and 16% lower than its last 4 quarters average of 3.4
The revenue is up by 38% year-on-year and by 5% since the previous quarter

Efficiency

How efficient is Progyny business performance
The return on sales has surged by 107% year-on-year and by 15% since the previous quarter
PGNY's return on invested capital has surged by 100% year-on-year and by 2.8% since the previous quarter
Progyny's return on assets has increased by 40% YoY and by 10% QoQ
The company's return on equity rose by 37% YoY and by 9% QoQ

Dividends

What is PGNY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PGNY.

Financial health

How did Progyny financials performed over time
PGNY's total assets is up by 39% YoY and by 4.1% from the previous quarter
Progyny's current ratio has increased by 26% YoY and by 9% QoQ
The company's debt is 97% lower than its equity
The company's debt has surged by 166% YoY but it fell by 2.6% QoQ
PGNY's debt to equity has surged by 50% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.